Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
- 1 December 1989
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 86 (23) , 9544-9548
- https://doi.org/10.1073/pnas.86.23.9544
Abstract
Human immunodeficiency virus type 1 (HIV-1) contains an open reading frame called nef at the 39 end of its genome. The nef gene product has been reported to down-regulate viral growth by suppressing viral transcription through interaction with the long terminal repeat region. We have compared two isogenic HIV-1 (HIV-1-WI3) strains, one of which lacks nef expression, and found little difference between them in in vitro growth. We tested effects on viral entry, DNA synthesis, and RNA expression by measuring HIV-specific low molecular weight DNA and RNA after infection. The qualitative and quantitative aspects of DNA and RNA synthesis were comparable between the nef+ and nef- strains. The effects on viral growth were also examined by following changes in reverse transcriptase activity during the course of infection. The presence of the nef gene product failed to slow viral growth in several different cell types tested, including the human T-lymphocyte cell lines H9 and CEM-SS, human primary T cells enriched for CD4+ cells, and human monocytic cell lines U-937 and THP-1. On the contrary, the nef+ strain grew more efficiently in some cell types than the nef- strain. The same results were obtained with nef+ and nef- strains of a different virus, HIV-1-432, whose Nef had been reported to have a negative effect on viral growth. Our data suggest that the Nef protein does not act as a negative factor, at least in the experimental systems employed in our studies.This publication has 25 references indexed in Scilit:
- Detection of specific sequences among DNA fragments separated by gel electrophoresisPublished by Elsevier ,2006
- HIV/HTLV gene nomenclatureNature, 1988
- Use of a Sensitive Neutralization Assay to Measure the Prevalence of Antibodies to the Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1988
- HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene productNature, 1987
- Infectious Mutants of HTLV-III with Changes in the 3′ Region and Markedly Reduced Cytopathic EffectsScience, 1986
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Nucleotide sequence and evolution of a mammalian α-Tubulin messenger RNAJournal of Molecular Biology, 1981
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976